NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $667,000 | -28.4% | 40,200 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $931,000 | +21.9% | 40,200 | -6.1% | 0.00% | 0.0% |
Q1 2020 | $764,000 | +31.0% | 42,800 | +58.5% | 0.00% | 0.0% |
Q4 2019 | $583,000 | -60.8% | 27,000 | -66.9% | 0.00% | -50.0% |
Q3 2019 | $1,487,000 | -45.4% | 81,618 | +6.7% | 0.00% | -50.0% |
Q2 2019 | $2,723,000 | -3.8% | 76,518 | -9.2% | 0.00% | 0.0% |
Q1 2019 | $2,830,000 | +2.7% | 84,241 | +0.5% | 0.00% | -20.0% |
Q4 2018 | $2,755,000 | -49.3% | 83,814 | -6.0% | 0.01% | -37.5% |
Q3 2018 | $5,433,000 | +17.5% | 89,119 | -5.9% | 0.01% | +14.3% |
Q2 2018 | $4,624,000 | -65.9% | 94,693 | -25.8% | 0.01% | -66.7% |
Q1 2018 | $13,561,000 | +895.7% | 127,620 | +459.7% | 0.02% | +950.0% |
Q4 2017 | $1,362,000 | +255.6% | 22,800 | +39.9% | 0.00% | +100.0% |
Q1 2017 | $383,000 | +74.1% | 16,300 | -8.9% | 0.00% | – |
Q4 2016 | $220,000 | -29.3% | 17,900 | -1.1% | 0.00% | -100.0% |
Q3 2016 | $311,000 | +35.2% | 18,100 | -4.7% | 0.00% | – |
Q1 2014 | $230,000 | +6.5% | 19,000 | 0.0% | 0.00% | – |
Q4 2013 | $216,000 | +20.7% | 19,000 | +11.1% | 0.00% | – |
Q3 2013 | $179,000 | -9.6% | 17,100 | 0.0% | 0.00% | – |
Q2 2013 | $198,000 | – | 17,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
TOBAM | 640,547 | $21,522,000 | 1.09% |
Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |